SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

443.742985

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

28.65

975.57

EPS(TTM)

Face Value()

Div & Yield %

63.45

0.03

Back

fredun pharmaceuticals ltd

Fredun Pharmaceuticals standalone net profit rises 127.87% in the September 2025 quarter

Nov 10,2025

Net profit of Fredun Pharmaceuticals rose 127.87% to Rs 9.73 crore in the quarter ended September 2025 as against Rs 4.27 crore during the previous quarter ended September 2024. Sales rose 34.33% to Rs 143.59 crore in the quarter ended September 2025 as against Rs 106.89 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	143.59	106.89	34
OPM %	15.55	13.04	-
PBDT	14.60	8.63	69
PBT	13.00	7.57	72
NP	9.73	4.27	128

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)